2021 Q3 Form 10-Q Financial Statement

#000119312521328922 Filed on November 15, 2021

View on sec.gov

Income Statement

Concept 2021 Q3
Revenue $13.99M
YoY Change 957.22%
Cost Of Revenue $6.381M
YoY Change 792.45%
Gross Profit $7.606M
YoY Change 1150.99%
Gross Profit Margin 54.38%
Selling, General & Admin $437.8M
YoY Change 632.8%
% of Gross Profit 5755.67%
Research & Development $254.3M
YoY Change 161.02%
% of Gross Profit 3342.87%
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $692.0M
YoY Change 340.37%
Operating Profit -$684.4M
YoY Change 337.22%
Interest Expense $474.5M
YoY Change 463.13%
% of Operating Profit
Other Income/Expense, Net -$15.35M
YoY Change 63.93%
Pretax Income -$225.2M
YoY Change 326.69%
Income Tax $401.0K
% Of Pretax Income
Net Earnings -$225.6M
YoY Change 321.77%
Net Earnings / Revenue -1613.21%
Basic Earnings Per Share -$0.32
Diluted Earnings Per Share -$320.6K
COMMON SHARES
Basic Shares Outstanding 650.2M
Diluted Shares Outstanding 650.2M

Balance Sheet

Concept 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.497B
YoY Change 13774472.53%
Cash & Equivalents $2.497B
Short-Term Investments
Other Short-Term Assets $46.11M
YoY Change 288075.0%
Inventory
Prepaid Expenses
Receivables $9.814M
Other Receivables $2.502M
Total Short-Term Assets $2.556B
YoY Change 7488191.83%
LONG-TERM ASSETS
Property, Plant & Equipment $80.10M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $436.8M
YoY Change
Other Assets $30.27M
YoY Change 5974.78%
Total Long-Term Assets $547.2M
YoY Change 109705.94%
TOTAL ASSETS
Total Short-Term Assets $2.556B
Total Long-Term Assets $547.2M
Total Assets $3.103B
YoY Change 582692.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $77.16M
YoY Change 234994.45%
Accrued Expenses $115.6M
YoY Change 33394.29%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $303.4M
YoY Change 52395.33%
LONG-TERM LIABILITIES
Long-Term Debt $199.9M
YoY Change
Other Long-Term Liabilities $148.7M
YoY Change
Total Long-Term Liabilities $348.6M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $303.4M
Total Long-Term Liabilities $348.6M
Total Liabilities $1.065B
YoY Change 184124.45%
SHAREHOLDERS EQUITY
Retained Earnings -$2.209B
YoY Change
Common Stock $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.038B
YoY Change
Total Liabilities & Shareholders Equity $3.103B
YoY Change 582692.91%

Cashflow Statement

Concept 2021 Q3
OPERATING ACTIVITIES
Net Income -$225.6M
YoY Change 321.77%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$120.6M
YoY Change 23.0%
INVESTING ACTIVITIES
Capital Expenditures -$2.761M
YoY Change 111.9%
Acquisitions
YoY Change
Other Investing Activities $320.2M
YoY Change -57171.3%
Cash From Investing Activities $317.4M
YoY Change -17128.38%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 303.9M
YoY Change 72.73%
NET CHANGE
Cash From Operating Activities -120.6M
Cash From Investing Activities 317.4M
Cash From Financing Activities 303.9M
Net Change In Cash 500.7M
YoY Change 558.47%
FREE CASH FLOW
Cash From Operating Activities -$120.6M
Capital Expenditures -$2.761M
Free Cash Flow -$117.8M
YoY Change 21.8%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Registrant Name
EntityRegistrantName
Roivant Sciences Ltd.
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00000003
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00000003
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
0
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
0
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4245860000
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3814805000
CY2021Q3 roiv Subscriptions Receivable
SubscriptionsReceivable
0
CY2021Q1 roiv Subscriptions Receivable
SubscriptionsReceivable
-100000000
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2209126000
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1918462000
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1281000
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1445000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
2038015000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
1797788000
CY2021Q3 us-gaap Minority Interest
MinorityInterest
390393000
CY2021Q1 us-gaap Minority Interest
MinorityInterest
241726000
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2428408000
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2039514000
CY2021Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.32
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.45
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
CY2021Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
650225764
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
628779048
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
650041993
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
628779048
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2039514000
CY2021Q2 roiv Issuance Of Subsidiary Warrants
IssuanceOfSubsidiaryWarrants
2075000
CY2021Q2 roiv Capital Contributions To Subsidiaries
CapitalContributionsToSubsidiaries
0
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
19269000
CY2021Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-2439000
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-101078000
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1957341000
CY2021Q3 roiv Stock Issued During Period Value Common Shares Upon Closing Of Business Combination And Pipe Financing
StockIssuedDuringPeriodValueCommonSharesUponClosingOfBusinessCombinationAndPipeFinancing
129097000
CY2021Q3 roiv Stock Issued During Period Value Common Shares Related To Settlement Of Transaction Consideration
StockIssuedDuringPeriodValueCommonSharesRelatedToSettlementOfTransactionConsideration
0
CY2021Q3 roiv Stock Issued During Period Value Subsidiary Preferred Shares
StockIssuedDuringPeriodValueSubsidiaryPreferredShares
70000000
CY2021Q3 roiv Stock Issued During Period Value Subsidiary Common And Preferred Shares To The Company
StockIssuedDuringPeriodValueSubsidiaryCommonAndPreferredSharesToTheCompany
0
CY2021Q3 roiv Adjustments Of Payment Of Subscription Receivable Value Equity Component
AdjustmentsOfPaymentOfSubscriptionReceivableValueEquityComponent
100000000
CY2021Q3 roiv Capital Contributions To Subsidiaries
CapitalContributionsToSubsidiaries
0
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
397312000
CY2021Q3 roiv Repurchase Of Equity Awards
RepurchaseOfEquityAwards
-2247000
CY2021Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
2545000
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-225640000
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2428408000
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2086204000
CY2020Q2 roiv Issuance Of Subsidiary Common Shares Net Value
IssuanceOfSubsidiaryCommonSharesNetValue
181180000
CY2020Q2 roiv Issuance Of Subsidiary Common Shares To The Company Value
IssuanceOfSubsidiaryCommonSharesToTheCompanyValue
0
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
63000
CY2020Q2 roiv Deconsolidation Of Subsidiary
DeconsolidationOfSubsidiary
-3054000
CY2020Q2 roiv Repurchase Of Equity Awards
RepurchaseOfEquityAwards
-113000
CY2020Q2 roiv Capital Contributions To Subsidiaries
CapitalContributionsToSubsidiaries
0
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
14278000
CY2020Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-820000
CY2020Q2 us-gaap Profit Loss
ProfitLoss
-7977000
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2269761000
CY2020Q3 roiv Issuance Of Subsidiary Common Shares Net Value
IssuanceOfSubsidiaryCommonSharesNetValue
175917000
CY2020Q3 roiv Issuance Of Subsidiary Common Shares To The Company Value
IssuanceOfSubsidiaryCommonSharesToTheCompanyValue
0
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
119000
CY2020Q3 roiv Consolidation Of Unconsolidated Entity
ConsolidationOfUnconsolidatedEntity
9178000
CY2020Q3 roiv Capital Contributions To Subsidiaries
CapitalContributionsToSubsidiaries
0
CY2020Q3 roiv Adjustments Due To Transfer From To Noncontrolling Interest Value
AdjustmentsDueToTransferFromToNoncontrollingInterestValue
0
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13914000
CY2020Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-1034000
CY2020Q3 us-gaap Profit Loss
ProfitLoss
-53498000
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2414357000

Files In Submission

Name View Source Status
0001193125-21-328922-index-headers.html Edgar Link pending
0001193125-21-328922-index.html Edgar Link pending
0001193125-21-328922.txt Edgar Link pending
0001193125-21-328922-xbrl.zip Edgar Link pending
d203748d10q.htm Edgar Link pending
d203748d10q_htm.xml Edgar Link completed
d203748dex101.htm Edgar Link pending
d203748dex311.htm Edgar Link pending
d203748dex312.htm Edgar Link pending
d203748dex321.htm Edgar Link pending
d203748dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
roiv-20210930.xsd Edgar Link pending
roiv-20210930_cal.xml Edgar Link unprocessable
roiv-20210930_def.xml Edgar Link unprocessable
roiv-20210930_lab.xml Edgar Link unprocessable
roiv-20210930_pre.xml Edgar Link unprocessable
Show.js Edgar Link pending